Crohn's Disease clinical trials
Showing 51–100 of 136 active trials. Describe your situation to see which ones you may be eligible for.
- Evaluation of the SMART IBD App in Pediatric IBD
- An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
- Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease
- Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis
- A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
- Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
- 68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
- A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
- Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
- Helmsley 3.0: Abbreviated MRE
- Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
- VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
- Therapeutic Endpoint in Pediatric IBD Conditions
- Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- Immune Regulation in Ulcerative Colitis or Crohn s Disease
- Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD
- COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
- IBD Pregnancy Registry
- ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
- Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- Urine Metabolites in the Diagnosis of Disease
- Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
- Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease
- Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
- Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
- Registry and Biorepository for IBD in Central Texas
- High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
- Inflammatory Bowel Disease (IBD) Research Registry
- Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
- A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
- Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
- Standardized Microbiota Transplant Therapy in Crohn's Disease
- Impact of Prebiotics in Ulcerative Colitis
- A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis
- Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
- Cranberry and Gut Health in Crohn's Disease
- Beta-Hydroxybutyrate Feasibility Treating IBD
- A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
- Diet and Stress Management Combined With Advanced Therapy for Crohn's and Ulcerative Colitis
- Feasibility Test of Action Planning in Pediatric IBD
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.